# CMV-TCR-T Cells for Refractory CMV Infection After HSCT

> **NCT05089838** · PHASE1 · UNKNOWN · sponsor: **Xiao-Jun Huang** · enrollment: 12 (estimated)

## Conditions studied

- Allogeneic Hematopoietic Stem Cell Transplantation
- CMV Infection

## Interventions

- **BIOLOGICAL:** CMV-TCR-T cells

## Key facts

- **NCT ID:** NCT05089838
- **Lead sponsor:** Xiao-Jun Huang
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-01-06
- **Primary completion:** 2023-10
- **Final completion:** 2023-10
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2021-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05089838

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05089838, "CMV-TCR-T Cells for Refractory CMV Infection After HSCT". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05089838. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*